Total Revenue
Idexx Laboratories Total Revenue increased by 4.6% to $1.14B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.3%, from $998.43M to $1.14B. Over 4 years (FY 2021 to FY 2025), Total Revenue shows an upward trend with a 7.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing market demand or successful price increases, while a decrease suggests market saturation or competitive pressure.
Detailed definition
The total amount of income generated by the sale of goods or services related to the company's primary operations. For a...
Peer comparison
Peer technology firms typically report this as Net Sales or Total Revenue, reflecting the scale of their market reach.
total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $826.14M | $810.42M | $801.09M | $836.55M | $860.55M | $841.66M | $828.57M | $900.20M | $943.63M | $915.53M | $901.60M | $964.10M | $1.00B | $975.54M | $954.29M | $998.43M | $1.11B | $1.11B | $1.09B | $1.14B |
| QoQ Change | — | -1.9% | -1.2% | +4.4% | +2.9% | -2.2% | -1.6% | +8.6% | +4.8% | -3.0% | -1.5% | +6.9% | +4.1% | -2.8% | -2.2% | +4.6% | +11.1% | -0.4% | -1.3% | +4.6% |
| YoY Change | — | — | — | — | +4.2% | +3.9% | +3.4% | +7.6% | +9.7% | +8.8% | +8.8% | +7.1% | +6.4% | +6.6% | +5.8% | +3.6% | +10.6% | +13.3% | +14.3% | +14.3% |
Product Breakdown
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| IDEXX VetLab consumables | $325.35M | $329.13M | $331.85M | $344.78M | $375.11M | $387.81M | $389.05M | $412.58M |
| Reference laboratory diagnostic and consulting services | $347.37M | $328.38M | $316.03M | $344.41M | $367.69M | $362.73M | $349.25M | $386.18M |
| Rapid assay products | $103.29M | $92.77M | $77.38M | $84.03M | $100.24M | $88.64M | $76.04M | $84.94M |
| Recurring revenue | $63.12M | $64.64M | $62.90M | $65.79M | $68.95M | $70.99M | $70.60M | $73.54M |
| CAG Diagnostics capital - instruments | $35.29M | $29.53M | $33.02M | $31.99M | $58.60M | $51.48M | $58.13M | $42.45M |
| CAG Diagnostics services and accessories | $32.44M | $33.16M | $32.20M | $33.05M | $34.95M | $34.10M | $35.33M | $36.61M |
| Systems and hardware | $15.44M | $14.38M | $17.11M | $15.78M | $16.89M | $16.79M | $20.07M | $17.75M |
| Total | $1.00B | $975.54M | $954.29M | $998.43M | $1.11B | $1.11B | $1.09B | $1.14B |
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Water segment revenue | $46.73M | $50.16M | $45.15M | $45.32M | $51.00M | $54.30M | $50.53M | $50.27M |
| LPD | $30.31M | $28.99M | $34.56M | $28.60M | $31.76M | $33.94M | $37.49M | $32.48M |
| CAG | — | — | $870.47M | — | — | — | $998.47M | — |
| Other segment revenue | $4.25M | $4.40M | — | — | — | — | — | — |
| Total | $1.00B | $975.54M | $954.29M | $998.43M | $1.11B | $1.11B | $1.09B | $1.14B |
LPD segment revenue, Other segment revenue were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Geographic Breakdown
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Europe, the Middle East and Africa | $200.69M | $198.61M | $207.61M | $204.55M | $233.27M | $245.06M | $254.37M | $257.05M |
| Asia Pacific | $80.44M | $80.97M | $83.31M | $81.73M | $89.30M | $90.72M | $94.17M | $94.38M |
| Latin America & Caribbean | — | — | $21.15M | — | — | — | $25.06M | — |
| Other | — | — | $27.53M | — | — | — | $31.09M | — |
| Total | $1.00B | $975.54M | $954.29M | $998.43M | $1.11B | $1.11B | $1.09B | $1.14B |
Americas, Other are derived from annual filings.
Total Revenue at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's total revenue?
- Idexx Laboratories (IDXX) reported total revenue of $1.14B in Q1 2026.
- How has Idexx Laboratories's total revenue changed year-over-year?
- Idexx Laboratories's total revenue increased by 14.3% year-over-year, from $998.43M to $1.14B.
- What is the long-term trend for Idexx Laboratories's total revenue?
- Over 4 years (2021 to 2025), Idexx Laboratories's total revenue has grown at a 7.6% compound annual growth rate (CAGR), from $3.22B to $4.30B.
- What does total revenue mean?
- The total amount of money a company brings in from selling its products and services.